| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,102 |
1,788 |
$569.28 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,279 |
2,774 |
$218.16 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,436 |
2,189 |
$80.72 |
| 80061 |
Lipid panel |
4,339 |
4,298 |
$0.00 |
| 99442 |
|
1,695 |
1,638 |
$0.00 |
| 3078F |
|
1,163 |
1,041 |
$0.00 |
| 82540 |
|
1,320 |
1,310 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,558 |
1,454 |
$0.00 |
| 3077F |
|
326 |
308 |
$0.00 |
| 80074 |
|
216 |
216 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
453 |
383 |
$0.00 |
| 90653 |
|
97 |
96 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
642 |
405 |
$0.00 |
| 86703 |
|
848 |
846 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
531 |
526 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
60 |
60 |
$0.00 |
| 82274 |
|
773 |
771 |
$0.00 |
| 84439 |
|
239 |
234 |
$0.00 |
| 81003 |
|
28 |
26 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
57 |
56 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
90 |
90 |
$0.00 |
| 3051F |
|
94 |
91 |
$0.00 |
| 3046F |
|
27 |
27 |
$0.00 |
| 86480 |
|
78 |
78 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
24 |
$0.00 |
| 91300 |
|
99 |
98 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
94 |
87 |
$0.00 |
| 85610 |
|
178 |
170 |
$0.00 |
| 77062 |
|
51 |
51 |
$0.00 |
| 90750 |
|
77 |
77 |
$0.00 |
| 98966 |
|
13 |
12 |
$0.00 |
| 84481 |
|
14 |
13 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
105 |
98 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,803 |
4,736 |
$0.00 |
| 1220F |
|
325 |
321 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
7,920 |
7,156 |
$0.00 |
| 99441 |
|
233 |
223 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
573 |
567 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
934 |
899 |
$0.00 |
| 3074F |
|
922 |
845 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
267 |
266 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
5,218 |
4,907 |
$0.00 |
| 3075F |
|
355 |
346 |
$0.00 |
| 82043 |
|
1,319 |
1,309 |
$0.00 |
| 99443 |
|
225 |
222 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
531 |
526 |
$0.00 |
| 85027 |
|
666 |
626 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
778 |
773 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
566 |
557 |
$0.00 |
| 90674 |
|
44 |
44 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,945 |
2,674 |
$0.00 |
| 90686 |
|
75 |
75 |
$0.00 |
| 3079F |
|
310 |
300 |
$0.00 |
| 4450F |
|
277 |
276 |
$0.00 |
| 3044F |
|
591 |
586 |
$0.00 |
| 86780 |
|
439 |
437 |
$0.00 |
| 84153 |
|
41 |
39 |
$0.00 |
| 1111F |
|
416 |
365 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
141 |
135 |
$0.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13 |
13 |
$0.00 |
| 92227 |
|
26 |
26 |
$0.00 |
| 3080F |
|
88 |
86 |
$0.00 |
| 92250 |
|
12 |
12 |
$0.00 |
| 81001 |
|
69 |
66 |
$0.00 |
| 90656 |
|
67 |
67 |
$0.00 |
| 3052F |
|
12 |
12 |
$0.00 |
| 88142 |
|
26 |
26 |
$0.00 |
| 82728 |
|
12 |
12 |
$0.00 |